Case Study: Sponsor navigates a complex autologous cell therapy trial with Precision for Medicine Central Lab Services

Sponsor treats 8 patients in rare cell therapy trial with Precision for Medicine (Central Lab Services)

The sponsor, a small biotech company, faced significant operational complexity in its early-phase autologous cell therapy trial for a rare post-transplant autoimmune complication. The challenge involved managing stringent patient eligibility, aligning unpredictable patient readiness with fixed manufacturing slots, and navigating a hesitant investigator community, all while working with Precision for Medicine for central lab services.

Precision for Medicine implemented a solution focused on rigorous daily coordination, transparent communication with the sponsor and investigators, and adaptive operational pivots. This included managing manufacturing slot alignment, reinforcing site engagement, and improving sample logistics. The results included the successful treatment of eight patients and the maintenance of strong site relationships and sponsor trust, which led to a data-informed and responsible decision to discontinue enrollment when the clinical objective was deemed unachievable.

Sponsor